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Objective. Lupus flares occur when genetically
predisposed individuals encounter appropriate environ-
mental agents. Current evidence indicates that the
environment contributes by inhibiting T cell DNA
methylation, causing overexpression of normally si-
lenced genes. DNA methylation depends on both dietary
transmethylation micronutrients and ERK-regulated
DNA methyltransferase 1 (DNMT-1) levels. We used
transgenic mice to study the effect of interactions be-
tween diet, DNMT-1 levels, and genetic predisposition
on the development and severity of lupus.
Methods. A doxycycline-inducible ERK defect was
bred into lupus-resistant (C57BL/6) and lupus-susceptible
(C57BL/6  SJL) mouse strains. Doxycycline-treated
mice were fed a standard commercial diet for 18 weeks
and then switched to a transmethylation micronutrient–
supplemented (MS) or –restricted (MR) diet. Disease
severity was assessed by examining anti–double-
stranded DNA (anti-dsDNA) antibody levels, the pres-
ence of proteinuria and hematuria, and by histopatho-
logic analysis of kidney tissues. Pyrosequencing was
used to determine micronutrient effects on DNA
methylation.
Results. Doxycycline induced modest levels of
anti-dsDNA antibodies in C57BL/6 mice and higher
levels in C57BL/6  SJL mice. Doxycycline-treated
C57BL/6  SJL mice developed hematuria and glomer-
ulonephritis on the MR and standard diets but not the
MS diet. In contrast, C57BL/6 mice developed kidney
disease only on the MR diet. Decreasing ERK signaling
and methyl donors also caused demethylation and over-
expression of the CD40lg gene in female mice, consistent
with demethylation of the second X chromosome. Both
the dietary methyl donor content and the duration of
treatment influenced methylation and expression of the
CD40lg gene.
Conclusion. Dietary micronutrients that affect
DNA methylation can exacerbate or ameliorate disease
in this transgenic murine lupus model, and contribute
to lupus susceptibility and severity through genetic–
epigenetic interactions.
Systemic lupus erythematosus (SLE) affects1.5
million Americans, 90% of whom are women (1). Lupus
involves many organs, including the joints, skin, kidneys,
heart, lungs, blood vessels, and brain. Disease ensues
when abnormally functioning B and T lymphocytes form
autoantibodies to DNA and nuclear proteins, resulting
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in immune complex deposition that causes inflammation
and tissue damage. While the cause(s) of SLE are
unknown, its etiology involves genes that confer suscep-
tibility, as well as hormones and environmental factors
(1,2). Evidence for a genetic contribution comes from
familial clustering of lupus cases in which siblings of
lupus patients have a 10–20-fold higher risk than the
general population of developing SLE, a higher concor-
dance rate in monozygotic twins (20%) than in dizygotic
twins (2%), and known lupus-associated polymorphisms
in genes, including those encoding HLA molecules,
complement components, cytokines, and programmed
cell death proteins (3).
The discordance of SLE between monozygotic
twins suggests that nongenetic factors may influence
gene expression, triggering lupus (4). However, what
these agents are and how they interact with the various
predisposing genetic loci to induce lupus are unclear.
DNA methylation and histone modifications regulate
gene expression through epigenetic mechanisms (5).
Drugs such as 5-azacytidine, procainamide, and hydral-
azine, as well as ultraviolet light, trigger lupus-like
autoimmunity through their effects on DNA methyl-
ation, resulting in autoreactive T cells that promote
autoimmunity (2). Reduced DNA methyltransferase 1
(DNMT-1) activity causes hypomethylation and over-
expression of the immune genes, including ITGAL
(CD11a), TNFSF7 (CD70), KIR genes, and CD40LG in
T lymphocytes (2,6).
ERK pathway signaling is an important DNMT-1
regulator, and ERK signaling is inhibited in T cells by
hydralazine, and in T cells from patients with idiopathic
lupus (2,7,8). Therefore, environmental agents that in-
hibit ERK signaling or its upstream regulator protein
kinase C, or other conditions, such as diet and aging,
that can decrease DNMT-1 enzymatic activity may
increase methylation-sensitive gene expression through
epigenetic mechanisms to cause lupus-like disease in
genetically predisposed individuals (2,9,10).
Diet is an important environmental compo-
nent and influences gene expression in vivo. When
administered to pregnant mice, diets rich in methyl
donors can alter DNA methylation patterns and gene
expression in developing embryos (11,12). Further-
more, dietary methyl donor supplementation can in-
crease total genomic dmC content in leukocyte DNA
(13), while dietary restriction of methyl donors leads
to DNA hypomethylation in vivo (14). Lupus patients
have significantly reduced levels of methylation-
associated micronutrients (15,16). We therefore tested
the hypothesis that dietary micronutrients necessary
for transmethylation influence lupus disease severity.
We have previously developed a transgenic mouse
model with an inducible T cell ERK pathway signaling
defect that results in demethylation and overexpression
of methylation-sensitive genes, causing the development
of lupus-like autoimmunity in female mice (17). In the
present study we used this model to examine the inter-
action of genes and micronutrients as a potential envi-
ronmental influence on SLE disease activity and se-
verity. We examined the effect of transmethylation
micronutrient–restricted (MR) and transmethylation
micronutrient–supplemented (MS) diets on the expres-
sion of methylation-sensitive T cell genes and lupus
disease, using mice with the inducible T cell DNA
methylation defect on a lupus-resistant (C57BL/6) or
lupus-susceptible (C57BL/6 x SJL) hybrid genetic back-
ground.
MATERIALS AND METHODS
Animals. SJL/J mice were purchased from The Jackson
Laboratory. C57BL/6 mice bearing the TRE-containing
dominant-negative MEK (dnMEK) transgene were bred with
C57BL/6 mice containing the reverse tetracycline trans-
activator under the control of the CD2 promoter (CD2-rtTA).
Double-transgenic (dnMEKCD2rtTA) mice inducibly ex-
press a dominant-negative MEK selectively in T lymphocytes
in the presence of doxycycline, leading to 60% reduction in
ERK phosphorylation (17). In the absence of either transgene,
doxycycline administration fails to reduce ERK phosphoryla-
tion.
Female double-transgenic mice with the following ge-
netic backgrounds and characteristics were generated for the
present study. The dnMEKCD2rtTA parental (P0) strain
C57BL/6 was anti–double-stranded DNA (anti-dsDNA) posi-
tive and lupus nephritis negative (17). The dnMEKCD2rtTA
F1 strain (C57BL/6  SJL)F1 was anti-dsDNA positive and
lupus nephritis positive (17,18). The dnMEK/CD2rtTA F2
strain was (F1  SJL)F2 (present study).
The animals were housed in filter-protected cages and
provided with standard, irradiated rodent diet 5053 (Lab Diet;
PMI Nutrition International) and water ad libitum. Selected
groups of mice received 4 mg/ml doxycycline (Sigma)/5%
sucrose in their drinking water. Protein and hemoglobin in
mouse urine were measured using a Chemstrip 7 dipstick
(Roche). All mice were bred and maintained in a specific
pathogen–free facility by the Unit for Laboratory Animal
Medicine at the University of Michigan in accordance with the
National Institutes of Health and the Association for Assess-
ment and Accreditation of Laboratory Animal Care Interna-
tional Guidelines. All procedures were approved by the Uni-
versity of Michigan Institutional Animal Care and Use
Committee.
Diets. Diets were selected to represent a range of DNA
transmethylation micronutrient concentrations. The concen-
trations of methyl donors and cofactors were based on the
micronutrient content of the diets used by Hollingsworth et al
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(19) and Delaney et al (20). Amino acid–defined MR
(TD.06688) and MS (TD.06690) containing the transmethyla-
tion micronutrients and cofactors listed in Table 1 were
provided by Harlan Laboratories. Mineral and vitamin pre-
mixes were AIN-93M and AIN-93, respectively. The MR diet
has low methionine (0.15%), moderate cysteine (0.25%), and
levels of methyl-related nutrients (choline, folate, vitamin B12,
and vitamin B6) that are within ranges typically found in other
purified or standard diets, including 5053. The MS diet has
higher methionine than standard diets (1.18%), moderate
cysteine (0.25%), and is supplemented with the methyl donors
choline and betaine. It also contains specific increases in
vitamin B12, folic acid, and zinc content compared to the
standard 5053 and MR diets. The MS diet was 8-fold higher
in methionine, 14-fold higher in choline, 5 times higher in folic
acid, and 25 times higher in vitamin B12 than the MR diet. The
standard natural ingredient rodent diet 5053 had intermediate
levels of methionine but was similar to the MR diet with regard
to levels of other methylation-associated micronutrients.
Flow cytometric analysis. Mouse spleen cells were
washed twice in standard buffer (phosphate buffered saline
[PBS] containing 1% horse serum and 1 mg/ml sodium azide)
at 4°C. Nonspecific binding was blocked by incubating the cells
for 1 hour on ice in standard buffer containing 10% horse
serum. The cells were then stained in the dark for 1 hour with
phycoerythrin (PE)–conjugated hamster anti-mouse CD154
(CD40L), PE-Cy5–conjugated rat anti-mouse CD4, or anti-
CD11a (BD PharMingen), washed, then fixed in 2% parafor-
maldehyde and stored in the dark at 4°C. The cells were
analyzed using a FACSCalibur flow cytometer (BD Biosci-
ences) as previously described (21).
Enzyme-linked immunosorbent assay (ELISA). Mouse
IgG anti-dsDNA antibodies were measured by ELISA as
previously described (18). Briefly, 96-well flat-bottomed micro-
titer plates (Costar) were coated overnight at 4°C with 10
g/ml of dsDNA in PBS, pH 7.2. Mouse sera or murine
monoclonal IgG anti-dsDNA antibody standard (Clone BV16-
13; Millipore) were added in various dilutions and incubated
overnight at 4°C. Bound anti-dsDNA antibody was detected
using horseradish peroxidase–conjugated goat anti-mouse
IgG-Fc–specific antibody (Bethyl Laboratories) and OneStep
Ultra tetramethylbenzidine substrate (Thermo) and measured
at 450 nm.
Bisulfite conversion and pyrosequencing. Genomic
DNA was isolated from CD4 T cells using a DNeasy blood
and tissue kit (Qiagen), and then bisulfite treated using an EZ
DNA Methylation Gold kit according to the recommendations
of the manufacturer (Zymo Research). Pyrosequencing prim-
ers for murine CD40lg were designed using PSQ Assay Design
software (Biotage). We have previously described their se-
quences and the polymerase chain reaction cycling parameters
for this gene (18).
Statistical analysis. Student’s t-test, chi-square tests, a
2-tailed Fisher’s exact test, and linear regression were used as
appropriate to determine the significance of differences be-
tween groups, using Systat software on a Dell PC Optiplex 745
microcomputer.
RESULTS
Influence of genetic background on anti-dsDNA
antibody levels. Inducing dnMEK expression by doxycy-
cline treatment in the double-transgenic mice decreased
ERK phosphorylation and DNMT-1 messenger RNA,
resulting in increased expression of the methylation-
sensitive genes Cd11a, Cd40lg, and Cd70, and induced
anti-dsDNA antibodies (17,18). The genetic background
of the mice confers additional factors that influence
lupus disease susceptibility and severity (22). We there-
fore compared the contribution of C57BL/6 (H2b) and
SJL (H2s) genetic backgrounds in influencing IgG anti-
dsDNA antibody titers in mice with the dnMEK and
CD2rtTA transgenes. Female C576BL/6, (B6  SJL)F1,
and (F1  SJL)F2 mice that were hemizygous for the
dnMEK and CD2rtTA transgenes were given drinking
water containing 4 mg/ml doxycycline/5% sucrose or 5%
sucrose alone. IgG anti-dsDNA antibody responses after
18 weeks of treatment are shown in Figure 1. Transgenic
(B6  SJL)F1 mice had significantly higher anti-dsDNA
antibody levels than mice with the transgenes on the
pure C57BL/6 background (P 0.03 by Student’s t-test).
Further increasing the SJL contribution to the genetic
background by a second backcross onto SJL significantly
increased the levels of IgG anti-dsDNA antibody pro-
duced (P  0.04 for F2 versus F1 and P  0.001 for F2
versus the pure C57BL/6 background). In the absence of
doxycycline treatment, no differences in anti-dsDNA
antibody levels were observed.
Although doxycycline-treated transgenic C57BL/6
mice produce anti-dsDNA antibody, they fail to develop
lupus-like organ damage and disease (17). SJL mice
possess genes that contribute to lupus-like disease when
ERK activity is impaired, but they do not spontaneously
develop lupus in the absence of doxycycline activation of
Table 1. Transmethylation micronutrient concentrations in mouse
diets*
MS diet
#06690
MR diet
#06688
Standard diet
5053
Methyl donors, gm/kg
Betaine 15 0 Unknown
Methionine 11.8 1.5 7
Choline 16.5 1.15 2
Methyl cofactors, mg/kg
Zinc 200 36 87
Folic acid 16.5 3 3
Vitamin B2 9 9 8
Vitamin B6 8.6 8.6 9.6
Vitamin B12 1.5625 0.0625 0.051
* MS  transmethylation micronutrient supplemented; MR  trans-
methylation micronutrient restricted.
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the transgene (17,18). We therefore investigated the
effect of dietary transmethylation micronutrients on the
epigenetic regulation of lupus susceptibility genes and
disease in these strains. Double-transgenic C57BL/6 and
(F1  SJL)F2 mice were fed the standard natural
ingredient rodent diet 5053 and given doxycycline in
their drinking water, as previously described (18). After
18 weeks, half of the mice were fed an MR diet while the
remaining animals were fed an MS diet, and all animals
continued to receive doxycycline. Anti-dsDNA antibody
levels significantly declined in (F1  SJL)F2 mice
switched to the MS diet (P  0.006 by linear regression)
and were near background levels 8 weeks later (Figure
2). In contrast (F1  SJL)F2 mice fed the MR diet
showed an increase in anti-dsDNA antibody levels,
although the change was not statistically significant (P
0.05).
Diet and hematuria. The effect of diet on the
development of kidney disease in mice was investigated.
We previously observed glomerulonephritis and hema-
turia in this transgenic mouse model of lupus (18). As
expected, doxycycline-treated transgenic C57BL/6 mice
failed to develop hematuria when fed the standard
rodent diet 5053 (Figure 3). They also failed to develop
hematuria when fed the MS diet. However, 6 of 18
doxycycline-treated, transgenic C57BL/6 mice devel-
oped hematuria when maintained on the MR diet.
Five of the 6 mice that developed hematuria had 250
erythrocytes/l. Four of the 6 animals that developed
Figure 1. Effect of genetic background on IgG anti–double-stranded
DNA (anti-dsDNA) antibody levels in mice. Mice bearing the
dominant-negative MEK and CD2 reverse tetracycline trans-activator
(CD2rt-TA) transgenes on the indicated genetic backgrounds were
treated for 18 weeks with doxycycline (DOX) in their drinking water or
did not receive doxycycline. Values are the mean  SEM; n values are
shown within the bars. P  0.03, F1 versus parental; P  0.042, F1
versus F2; P  0.001, F2 versus parental, by Student’s t-test. No
significant differences in anti-dsDNA antibody levels were observed
between groups in the absence of doxycycline treatment (P  0.05).
Figure 2. Decline in IgG anti–double-stranded DNA (anti-dsDNA)
antibody levels in doxycycline-treated transgenic (F1  SJL)F2 female
mice fed a transmethylation micronutrient–supplemented (MS) diet.
The arrow indicates the time point (18 weeks) when mice were
switched from a standard diet (rodent diet 5053) to either an MS diet
or a transmethylation micronutrient–restricted (MR) diet. Values are
the mean  SEM (n  5–10 mice per group). P  0.006, standard diet
(weeks 14–18) versus MS diet (weeks 20–26) by linear regression; P 
0.368, standard diet (weeks 14–18) versus MR diet (weeks 20–26) by
linear regression; P  0.01, MS diet versus MR diet at week 26 by
Student’s t-test.
Figure 3. Influence of diet on kidney function in mice. C57BL/6 (B6)
or (F1  SJL)F2 mice bearing the dominant-negative MEK and CD2
reverse tetracycline trans-activator transgenes were treated with doxy-
cycline in their drinking water and fed either a transmethylation
micronutrient–restricted (MR) diet, as standard rodent diet, or a
transmethylation micronutrient–supplemented (MS) diet for up to 18
weeks. Values above the bars are the number of mice with hematuria/
number of mice per group. The effect of diet on hematuria was
significant (P  0.01, MR diet versus both standard diet and MS diet
for both strains of mice, by chi-square test for trend in proportions).
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hematuria also had 30–50 mg/dl protein in their urine,
and 1 had a trace amount of protein in the urine. One
mouse had 100 erythrocytes/l (minimum detectable
level50 erythrocytes/l) and a trace amount of protein
in the urine. The effect of doxycycline treatment and the
MR diet on hematuria in the transgenic C57BL/6 mice
was statistically significant (P  0.01).
Two of 14 doxycycline-treated transgenic (F1 
SJL)F2 mice that were fed a standard diet developed
hematuria, with 50 erythrocytes/l and a trace amount
of urinary protein in one, and 500 erythrocytes/l and
30 mg/dl of urinary protein in the other. However, none
of the (F1  SJL)F2 mice fed the MS diet developed
hematuria. Of the 5 transgenic (F1  SJL)F2,
doxycycline-treated mice that were fed the MR diet, 1
had 100 erythrocytes/l and 30 mg/dl urinary protein,
and 1 had 500 erythrocytes/l and 100 mg/dl urinary
protein. In the absence of doxycycline, no hematuria
developed in either strain with any of the diets used
(data not shown). Increasing the dietary methyl donor
content reduced the development of hematuria signifi-
cantly in transgenic mice with SJL genes (P  0.01 by
chi-square test for trend in proportions).
The semiquantitative scoring system described
by Austin et al (23) to measure renal disease in lupus
patients was used to assess kidney damage in the mice.
Light microscopic examination of paraffin-embedded
sections of kidneys from doxycycline-treated mice con-
firmed that the transgenic C57BL/6 mice did not de-
velop kidney disease when fed the standard diet
(mean  SEM score 0  0) (Figure 4A). The glomeruli
of these animals were normal and exhibited open capil-
lary loops and no increase in cellularity. C57BL/6 ani-
mals fed the MR diet had focal glomerular hypercellu-
larity with an increase in mesangial matrix (mean 
SEM score 4.5  0.5 [range 4–5]).
The SJL background contains lupus susceptibility
genes which contribute to both the development and the
severity of glomerular inflammation. In (F1  SJL)F2
animals that were fed the standard diet, there was mild
focal glomerulonephritis with hypercellularity and in-
creased mesangial matrix (mean  SEM score 3.6  1.5
[range 1–7]). (F1 SJL)F2 animals fed the MR diet had
more severe glomerulonephritis than the C57BL/6 mice,
with a marked increase in diffuse glomerular hypercel-
lularity and matrix deposition with karyorrhectic nuclear
debris, and thickening of the glomerular capillary loops
consistent with subendothelial deposits (mean  SEM
score 5.8  2.0 [range 2–12]).
In the absence of doxycycline treatment, no ani-
mals developed kidney disease (results not shown).
Taken together, our data indicate that transmethylation
micronutrients, particularly methyl donors such as me-
thionine and betaine, can influence lupus-like disease
symptoms such as anti-dsDNA antibody levels and he-
maturia in a transgenic murine model of SLE.
CD40lg gene expression and methylation. CD40L
protein on T cells is elevated in women with lupus and
in our transgenic mouse model of lupus, and contributes
to disease pathogenesis by stimulating B cell antibody
production (24,25). The CD40L gene (CD40LG) is on
the X chromosome in both humans and mice, and its
aberrant demethylation on the inactive X may thus be a
determinant of lupus predominance in females com-
pared to males. Increased CD40LG expression with
decreased methylation in females but not males has
been demonstrated in both species (1,18,25). Therefore,
the effect of diet on murine CD40lg expression and
Figure 4. Diet and glomerulonephritis in mice. Formalin-fixed kid-
neys from transgenic doxycycline-treated C57BL/6 (P0) and (F1 
SJL)F2 mice were processed routinely, stained with hematoxylin
and eosin, and examined by light microscopy for evidence of disease.
A, Section from a C57BL/6 mouse fed a standard commercial diet
(rodent diet 5053), showing normal glomeruli with no increase in
cellularity and open capillary loops (arrow) (group mean SEM lupus
renal disease score 0  0). B, Section from a C57BL/6 mouse fed a
transmethylation micronutrient–restricted (MR) diet. Note the in-
creased mesangial matrix (arrow). The lupus renal disease score was
4 for the section shown (group mean  SEM 4.5  0.5 [range 4–5]).
C, Section from an (F1  SJL)F2 mouse fed a standard commercial
diet (rodent diet 5053). Note the increased mesangial matrix (arrow).
The lupus renal disease score was 4 for the section shown (group
mean SEM 3.6 1.5 [range 1–7]). D, Section from an (F1 SJL)F2
mouse fed an MR diet. Karyorrhectic nuclear debris (black arrow) and
thickening of the glomerular capillary loops consistent with subendo-
thelial deposits (white arrows) are seen, and are more severe than in
the C57BL/6 mice. The lupus renal disease score was 12 for the section
shown (group mean  SEM 5.8  2.0 [range 2–12]).
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methylation was examined. CD4 T lymphocytes from
female transgenic, doxycycline-treated C57BL/6 mice
that were fed the MR diet overexpressed CD40L protein
relative to mice that were fed the MS diet (mean SEM
mean fluorescence intensity 3,089 466 for the MR diet
versus mean 864 [range 848–880] for the MS diet) (P 
0.017) (Figure 5A).
Impaired ERK signaling or inhibition of DNMT-1
contributed to increased CD40L protein on CD4 T
cells from female mice by inhibiting the methylation of
CG pairs in the promoter region near the transcription
start site (18,25). Therefore, the methylation of CG pairs
in this region was measured. After 12 weeks of doxycy-
cline treatment, transgenic C57BL/6 mice that were fed
the MR diet had reduced methylation of CG pairs
located 46, 43, and 35 bp 5	 of the transcription
start site of the CD40lg promoter compared with mice
that were fed the MS diet, although the reduction was
not statistically significant (Figure 5B). The methylation
levels at positions 43 and 35 (but not at position
46) continued to decline in mice that were fed the MR
diet, and at 32 weeks this decline was statistically signif-
icant compared to both the 12-week MS diet group and
the 12-week MR diet group. The CG pairs located 35
and 43 bp 5	 relative to the murine transcription start
site are homologous to regulatory CG pairs in the
human CD40LG promoter, and these are demethylated
in T cells from female lupus patients and 5-azacytidine–
treated T cells from healthy women (25). Demethyla-
tion required doxycycline treatment since no decline in
methylation levels in residues 76 through 35 was
observed in the absence of doxycycline (data not shown).
Figure 5. Effect of transmethylation micronutrient levels on CD40L protein expression and DNA methylation in CD4 T cells from female mice.
A, CD40L expression in spleen cells from dominant-negative MEK/CD2 reverse tetracycline trans-activator transgenic C57BL/6 female mice treated
with doxycycline (DOX) and fed either a transmethylation micronutrient–restricted (MR) diet or a transmethylation micronutrient–supplemented
(MS) diet for 18 weeks. Mouse spleen cells were stained for CD4 T cells and CD40L and analyzed by flow cytometry. Values are the mean SEM
(n  8) for the MR group and the mean and range (n  2) for the MS group. Significance was determined by chi-square test. B, Methylation of
CG pairs in the Cd40lg promoter in dnMEK/CD2rtTA transgenic C57BL/6 mice treated with doxycycline and fed an MS diet for 12 weeks, an
MR diet for 12 weeks, or an MR diet for 32 weeks. Values are the mean SEM (n 5–9 mice per group). Significance was determined by Student’s
t-test. MFI  mean fluorescence intensity; NS  not significant; TSS  transcription start site.
DIET, DNA METHYLATION, AND LUPUS 1877
This experiment confirms that diet and decreased
DNMT-1 synergize to inhibit DNA methylation in these
mice.
DISCUSSION
The development of SLE involves genes that
confer disease susceptibility, hormones, and environ-
mental factors (1,2). The present study investigated the
gene–environment interaction in lupus development and
severity using a double-transgenic lupus model with an
inducible ERK pathway signaling defect bred onto the
lupus-resistant C57BL/6 background or a lupus-susceptible
C57BL/6  SJL hybrid genetic background (17). These
mice express a dominant-negative MEK uniquely in
CD2 cells when doxycycline is administered in their
drinking water. Activation of the transgenes suppresses
ERK signaling and subsequent DNMT-1 expression,
leading to DNA hypomethylation and overexpression of
methylation-sensitive genes (17,18). This is similar to the
ERK signaling defect that contributes to human lupus
(26).
The results of the present study confirm previous
findings in this model that activation of the transgenes in
mice of the lupus-resistant C57BL/6 strain, fed a stan-
dard commercial laboratory diet, induced low levels of
anti-dsDNA antibody and DNA hypomethylation, and
that higher anti-dsDNA antibody levels and active kid-
ney disease required the presence of other lupus suscep-
tibility genes present in the SJL mouse strain (17).
Increasing the SJL genetic contribution by an additional
backcross further increased the levels of anti-dsDNA
antibody and disease severity, thus supporting our pre-
vious findings (1) correlating lupus disease severity and
the number of lupus-associated single-nucleotide poly-
morphisms in men and women with lupus.
The incomplete concordance of lupus between
genetically identical twins strongly supports the notion
that nongenetic factors are involved in the etiology of
SLE (4,27). Drugs such as hydralazine and procainamide
can trigger a lupus-like disease in genetically susceptible
individuals through their effects on mechanisms, such
as DNA methylation, histone modification, and signal
transduction, that control gene expression (8,28). DNA
methylation depends on DNMT-1 activity and
S-adenosyl methionine (SAM) levels, the latter of which
are regulated by methionine, choline, zinc, vitamins B2,
B6, and B12, and folate from dietary sources. Therefore,
we tested the hypothesis that dietary micronutrients
involved in transmethylation reactions can epigenetically
modify lupus gene expression and disease severity, in
experiments in which we continued to treat the trans-
genic mice with doxycycline following the induction of
SLE, but changed the diets to either a low methionine
formulation or a diet rich in methyl donors and cofac-
tors. Our results showed that reducing the methionine
and choline content of the diet increased lupus disease
severity in genetically susceptible hybrid mice and also
caused a milder kidney disease in mice with a lupus-
resistant C57BL/6 genetic background. In contrast, a
diet enriched in methyl donors and the cofactors zinc,
folic acid, and vitamin B12 ameliorated both the anti-
DNA antibody response and kidney disease. Taken
together, our results demonstrate that the onset and
severity of lupus disease can be influenced by both lupus
susceptibility genes and nongenetic factors that affect
DNA methylation.
It is tempting to speculate that the onset and/or
severity of human lupus may be modulated by dietary
intervention. Dietary modification has been used suc-
cessfully in rodent and human studies to influence
disease outcome and epigenetically alter the heritable
gene expression profile. For example, dietary folate
levels modulate hepatocyte DNA methylation in rats
(29). A low-folate diet caused DNA hypomethylation
in the lymphocytes of healthy postmenopausal women,
which could be reversed with a folate-supplemented diet
(14). There are limited data from studies of SLE patients
showing that supplementation with vitamin B6, vitamin
B12, and folate ameliorates lupus symptoms (30). How-
ever, Wu et al reported that 100 metabolites, many of
which contribute to energy metabolism, are significantly
altered in SLE patients (16). They further found that
methionine and other methyl donors, including cysteine,
choline, and cofactors such as vitamin B6, were signifi-
cantly reduced in SLE patients compared to healthy
matched controls. Folate depletion increases homocys-
teine (Hcy) levels, which decreases SAM production,
resulting in DNA hypomethylation (6,10).
Maintenance of T cell DNA methylation patterns
is more sensitive to low folate and methionine levels in
older individuals due to a decline in DNMT-1 levels that
occurs with age (10). DNMT-1 levels are also inversely
proportional to lupus disease activity (31), potentially
rendering people with active SLE more sensitive to low
levels of micronutrients required for DNA methylation
and potentially exacerbating immune dysregulation and
contributing to disease activity. Similarly, elevated levels
of folate or vitamin B6 suppressed expression of the
methylation-sensitive perforin gene in T cells from lupus
patients in vitro (15), supporting the notion that dietary
supplementation may have beneficial effects on SLE.
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Thus, attention to proper nutrition may be particularly
important in the elderly and in lupus patients.
The results of the present study show that diets
with low levels of methyl donors and cofactors, together
with impaired ERK signaling, cause progressive hypo-
methylation in CD40lg regulatory regions of CD4 T
cells, and that a methyl-supplemented diet prevents
DNA demethylation of this region. CD40L protein on T
cells plays an important role in stimulating autoantibody
production and is overexpressed in women, but not men,
with SLE due to activation of the CD40L gene on the
inactive X chromosome (18,25,32). Thus, dietary ap-
proaches that target a specific metabolic pathway such as
transmethylation, a key to lupus pathogenesis, are ra-
tional and potentially useful approaches to prevention
and perhaps therapy.
Successful dietary approaches to treat SLE will
probably require simultaneous targeting of multiple
elements of 1-carbon metabolism as well as other factors
that impact methylation pathways. Methionine partici-
pates as a methyl donor in SAM biosynthesis. The key
reaction in DNA methylation is the DNMT-catalyzed
transfer of methyl groups from SAM to dC bases at CpG
pairs in DNA, producing methylated (dmC) DNA and
S-adenosyl Hcy. Intracellular SAM pools are crucially
dependent on a number of dietary factors, including
folic acid, methionine, choline, betaine, zinc, and vita-
mins B6 and B12. While B vitamins and enzyme cofactors
are essential for methionine metabolism, they cannot
substitute for the required methyl group substrates. The
metabolism of methionine to Hcy and remethylation of
Hcy back to methionine is tightly controlled, such that
intracellular SAM levels tend to be maintained during
normal variations in dietary methionine content (33).
Betaine provides methyl groups for SAM by the action
of betaine-Hcy methyltransferases and 1-carbon units
via the folate system (34), and was included in the MS
diet. Betaine supplementation lowers Hcy levels and
elevates methionine levels, has been used as a safe and
effective treatment for 3 different forms of homocystin-
uria (33), and has been proposed as a therapy for neural
tube defects due to its ability to stimulate cellular
methylation reactions (33).
Selection of the methyl donor and cofactor con-
centrations used in the present study was based on
several studies by others in which diet was used to
modify DNA methylation and biologic responses
(12,36–38). The methionine concentration in the MR
diet represented the lowest methionine concentration
that could be tolerated over an extended period of time
(35). The MS diet was based on the formulation used by
Hollingsworth et al (19) and the amino acid–defined MS
diet used by Delaney et al (20) to study epigenetic
changes acquired in utero. Betaine and increased dietary
methionine, choline, and folate were used to boost the
concentration of methyl donors and cofactors and re-
sulted in hypermethylation of genes in embryos
(12,19,20). The MS diet used in the present study
reduced anti-dsDNA antibody levels to near background
levels in transgenic mice with defective ERK–triggered
lupus-like disease, suggesting that micronutrients that
enhance transmethylation reactions may ameliorate lu-
pus disease via epigenetic mechanisms. Similarly, the
reduced methionine content of the MR diet, together
with reduced ERK pathway activity, could have exacer-
bated lupus disease via epigenetic mechanisms by caus-
ing DNA hypomethylation and enhanced immune gene
expression.
The terms “low” and “high” used in reference to
the methyl donor and cofactor content of the diets used
in the present study are relative only to one another and
not to “natural” diets. Compared to the MR diet, the MS
diet had 8 times the amount of methionine, 14 times
the amount of choline, 5 times the amount of folic
acid,25 times the amount of vitamin B12, and 15 gm/kg
betaine. The methyl donor levels in the MS diet are
greater than those typically found in commercial rodent
diets. The MR diet has lower methionine levels than
the common purified diets AIN93G, 5053, and NIH-31
used in other studies of DNA methylation in vivo
(12,19,20,36). Levels of the other micronutrients, such as
folate, vitamin B6, and vitamin B12, are similar to those
in standard rodent diets.
While our murine study suggests that diets rich
in methyl donors may be beneficial for lupus patients,
due to size, metabolic rates, and differences in nutrient
requirements, extrapolating micronutrient levels from
rodents to humans is not straightforward. By expressing
dietary nutrient levels based on energy, which takes into
account the size and metabolic rates of the two species,
a rough comparison of dietary micronutrient levels may
be performed. Normal Western diets supply 2–4 gm
sulfur amino acids (methionine plus cysteine) per day,
147 g/kcal choline, 0.3 g/kcal folate, and 2.5 ng/kcal
vitamin B12 (37,38). Men 31–50 years old have an
average intake of 2.3 gm of methionine per day, while
the average for women is 1.6 gm/day. In a 2,000-kcal
diet, methionine represents 0.8–1.15 mg/kcal (38). Sup-
plementation with 5 gm of methionine per day is the
maximum dose tolerated in humans (39). The MS diet
used in the present study includes 3.1 mg methionine/
kcal, 3 times the typical human intake. The MS diet
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consists of 29 times the amount of choline, 14 times the
amount of folate, and 160 times the levels of vitamin B12
found in a Western diet. Betaine is included in the MS
diet at 3.9 mg/kcal, which is 37.5 times the amount found
in the human diet (40). The amount of methionine in the
MR diet is 0.375 mg/kcal, which is less than half the
amount of methionine consumed by adults who eat a
Western diet. The MR diet contains twice the amount of
choline and folate and 6 times the amount of vitamin B12
found in the Western diet.
In conclusion, our results indicate that it is pos-
sible to modulate autoantibody levels and kidney disease
severity by dietary manipulation in a mouse model of
SLE. These data suggest that dietary modification might
be a candidate therapeutic approach for future studies in
lupus patients.
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